BD British recall
This article was originally published in The Gray Sheet
Executive Summary
Firm removes reusable Vacutainer needle-holder from UK market in response to concerns voiced by British healthcare groups about "the risk of needlestick injury and cross contamination of patient blood," an Aug. 26 medical device alert from the Medicines & Healthcare products Regulatory Agency states. BD is replacing the reusable holder with a single-use iteration. The firm suggests remaining inventory be used and then discarded as a single-use model...
You may also be interested in...
EU: Good News For IVDs And For Future Transparency Of Medtech Compliance
The IVD industry has long been awaiting a further extension of the deadlines for compliance with the IVD Regulation and for the launch date of the Eudamed database to be brought forward.
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.